Paroxysmal atrial fibrillation is more prevalent than persistent atrial fibrillation in acute stroke and transient ischemic attack patients

Cerebrovascular Diseases

Volumn 32, Issue 3, 2011, Pages 276-282

  Rizos, T ^a   Wagner, A ^a   Jenetzky, E ^b   Ringleb, P A ^a   Becker, R ^a   Hacke, W ^a   Veltkamp, R ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Acute ischemic stroke; Atrial fibrillation cardiogenic embolism; Transient ischemic attack

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; DISEASE SEVERITY; EMERGENCY CARE; FEMALE; FOLLOW UP; GENDER; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PERSISTENT ATRIAL FIBRILLATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; STROKE; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK;

AGE FACTORS; AGED; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CHI-SQUARE DISTRIBUTION; FEMALE; GERMANY; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS;

EID: 80052307961     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000330348     Document Type: Article

References (37)

1. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al: ACC/AHA/ ESC 2006 guidelines for the management of patients with atrial fibrillation -executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology. JACC 2006; 48: 854-906.
2. Jørgensen H, Nakayama H, Reith J, Raaschou H, Olsen T: Acute stroke with atrial fibrillation: The Copenhagen Stroke Study. Stroke 1996; 27: 1765-1769. (Pubitemid 26332501)
3. Lip G, Beevers D: ABC of atrial fibrillation: History, epidemiology, and importance of atrial fibrillation. BMJ 1995; 311: 1361-1363.
4. Tsang T, Petty G, Barnes M, O'Fallon W, Bailey K, Wiebers D, et al: The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: Changes over three decades. JACC 2003; 42: 4293-4100.
5. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22: 983-988.
6. Hohnloser SH, Crijns HJGM, Eickels M van, Gaudin C, Page RL, Torp-Pedersen C, et al: Effect of dronedarone on cardiovascular events in atrial fibrillation. NEJM 2009; 360: 668-678.
7. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al: Dabigatran versus warfarin in patients with atrial fibrillation. NEJM 2009; 361: 1139-1151.
8. Adams HP, Zoppo G del, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al: Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atheros. Stroke 2007; 38: 1655-1711. (Pubitemid 46691097)
9. European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee: Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457-507.
10. Hart RG, Pearce LA, Aguilar MI: Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Int Med 2007; 146: 857-867. (Pubitemid 351650486)
11. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154: 1449-1457.
12. Hart RG, Benavente O, McBride R, Pearce LA: Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Ann Intern Med 1999; 131: 492-501. (Pubitemid 29482392)
13. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, et al: Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke. Stroke 2006; 37: 577-617.
14. Wann LS, Curtis a B, January CT, Ellenbogen KA, Lowe JE, Estes M, et al: 2011 ACCF/ AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): A report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Circulation 2011; 123: 104-123.
15. Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, et al: Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: An ACTIVE W Substudy. JACC 2007; 50: 2156-2161. (Pubitemid 350123679)
16. Nieuwlaat R, Dinh T, Olsson SB, Camm AJ, Capucci A, Tieleman RG, et al: Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? Eur Heart J 2008; 29: 915-922. (Pubitemid 351499500)
17. Friberg L, Hammar N, Rosenqvist M: Stroke in paroxysmal atrial fibrillation: Report from the Stockholm Cohort of Atrial Fibrillation. Euro Heart J 2010; 31: 967-975.
18. Jensen TJ, Haarbo J, Pehrson SM, Thomsen PEB: Paroxysmal atrial fibrillation: Ectopic atrial activity and prevalence of severely symptomatic patients. Pacing Clin Electrophysiol 2003; 26: 1668-1674. (Pubitemid 36936740)
19. Lévy S, Maarek M, Coumel P, Guize L, Lekieffre J, Medvedowsky JL, et al: Characterization of different subsets of atrial fibrillation in general practice in France: The ALFA study. The College of French Cardiologists. Circulation 1999; 99: 3028-3035. (Pubitemid 29270433)
20. Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett EL: Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994; 89: 224-227. (Pubitemid 24026493)
21. Roche F, Gaspoz J-M, Da Costa A, Isaaz K, Duverney D, Pichot V, et al: Frequent and prolonged asymptomatic episodes of paroxysmal atrial fibrillation revealed by automatic long-term event recorders in patients with a negative 24-hour Holter. Pacing Clin Electrophysiol 2002; 25: 1587-1593. (Pubitemid 35398919)
22. Patten M, Maas R, Karim A, Müller HW, Simonovsky R, Meinertz T: Event-recorder monitoring in the diagnosis of atrial fibrillation in symptomatic patients: Subanalysis of the SOPAT Trial. J Cardiovasc Electrophysiol 2006; 17: 1216-1220. (Pubitemid 44583865)
23. Rizos T, Rasch C, Jenetzky E, Hametner C, Kathoefer S, Reinhardt R, et al: Detection of paroxysmal atrial fibrillation in acute stroke patients. Cerebrovascular Diseases 2010; 30: 410-417.
24. Liao J, Khalid Z, Scallan C, Morillo C, O'Donnell M: Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: A systematic review. Stroke 2007; 38: 2935-2940. (Pubitemid 350035686)
25. Stahrenberg R, Weber-Krüger M, Seegers J, Edelmann F, Lahno R, Haase B, et al: Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous Holter monitoring in patients with cerebral ischemia presenting in sinus rhythm. Stroke 2010; 41: 2884-2888.
26. Douen AG, Pageau N, Medic S: Serial electrocardiographic assessments significantly improve detection of atrial fibrillation 2. 6-fold in patients with acute stroke. Stroke 2008; 39: 480-482. (Pubitemid 351619476)
27. Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, et al: Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Euro Heart J 2010; 31: 2369-2429.
28. Hart RG, Palacio S, Pearce LA: Atrial fibrillation, stroke, and acute antithrombotic therapy: Analysis of randomized clinical trials. Stroke 2002; 33: 2722-2727. (Pubitemid 35266448)
29. Hart RG, Halperin JL: Atrial fibrillation and stroke: Concepts and controversies. Stroke 2001; 32: 803-808.
30. Sandercock P, Bamford J, Dennis M, Burn J, Slattery J, Jones L, et al: Atrial fibrillation and stroke: Prevalence in different types of stroke and influence on early and long term prognosis. BMJ 1992; 305: 1460-1465.
31. Carolei A, Marini C, Di Napoli M, Di Gianfilippo G, Santalucia P, Baldassarre M, et al: High stroke incidence in the prospective community-based L'Aquila registry (1994-1998): First year's results. Stroke 1997; 28: 2500-2506. (Pubitemid 28007658)
32. Saxena R, Lewis S, Berge E, Sandercock PA, Koudstaal PJ: Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. Stroke 2001; 32: 2333-2337. (Pubitemid 32954805)
33. Marini C, De Santis F, Sacco S, Russo T, Olivieri L, Totaro R, et al: Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: Results from a population-based study. Stroke 2005; 36: 1115.
34. Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, et al: Risk factors, outcome, and treatment in subtypes of ischemic stroke: The German Stroke Data Bank. Stroke 2001; 32: 2559-2566. (Pubitemid 33055306)
35. Sinha A-M, Diener H-C, Morillo C, Sanna T, Bernstein RA, Di Lazzaro V, et al: Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF): Design and rationale. AHJ 2010; 160: 36-41.
36. Karatas M, Dilek A, Erkan H, Yavuz N, Sözay S, Akman N: Functional outcome in stroke patients with atrial fibrillation. Arch Phys Med Rehab 2000; 81: 1025-1029. (Pubitemid 30618656)
37. Kimura K, Minematsu K, Yamaguchi T: Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2005; 76: 679-683. (Pubitemid 40569678)